Micronase and Weight decreased - a phase IV clinical study of FDA data

Summary:

Weight decreased is reported as a side effect among people who take Micronase (glyburide), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Byetta, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Weight decreased when taking Micronase. It is created by eHealthMe based on reports of 1,913 people who have side effects when taking Micronase from the FDA, and is updated regularly.

What is Micronase?

Micronase has active ingredients of glyburide. eHealthMe is studying from 1,922 Micronase users. Check the latest studies of Micronase.

What is Weight decreased?

Weight decreased is found to be associated with 3,389 drugs and 4,750 conditions by eHealthMe. Check the latest studies of Weight decreased.

On Jul, 23, 2026

1,913 people reported to have side effects when taking Micronase.
Among them, 78 people (4.08%) have Weight decreased.

Among these 78 people:

How long have people been on Micronase when they have Weight decreased? *

What is the gender of people who have Weight decreased when taking Micronase? *

female: 34.21 %
male: 65.79 %

What is the age of people who have Weight decreased when taking Micronase? *

What are other drugs people take besides Micronase? *

What are other side effects people have besides Weight decreased? *

Nausea (feeling of having an urge to vomit): 25 people, 32.05%
Weakness: 22 people, 28.21%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 18 people, 23.08%
Fatigue (feeling of tiredness): 17 people, 21.79%
Blood Glucose Increased: 17 people, 21.79%
Cardiac Failure Congestive: 16 people, 20.51%
Fall: 15 people, 19.23%
Dizziness: 14 people, 17.95%
Heart Attack: 13 people, 16.67%
Constipation: 12 people, 15.38%

What are the existing conditions these people have? *

Type 2 Diabetes: 22 people, 28.21%
Diabetes: 3 people, 3.85%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 3.85%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 3.85%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 2.56%
Quit Smoking: 2 people, 2.56%
Blood Glucose Increased: 2 people, 2.56%
Back Pain: 2 people, 2.56%
Insulin-Requiring Type 2 Diabetes Mellitus: 1 person, 1.28%
Hypersensitivity: 1 person, 1.28%

* Approximation only. Some reports may have incomplete information.

Do you take Micronase and have Weight decreased?

- Check whether Weight decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micronase:

Micronase (1,922 reports)

Weight decreased treatments and more:

Weight decreased (364,522 reports)

Browse all side effects of Micronase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight decreased:

Weight decreased (3,389 drugs)

Browse all the conditions that are associated with Weight decreased:

Weight decreased (4,750 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glyburide (the active ingredients of Micronase) and Micronase (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.